Industry will see more unannounced inspe
In an Interview to CNBCTV18 during visit to India, USFDA Commissioner touched on different topics
Warning letters, 483s, Recalls, Import Alerts, Audit observations
In an Interview to CNBCTV18 during visit to India, USFDA Commissioner touched on different topics
The Warning letter cite Failure of Quality unit in ensuring cGMP compliance, Inadequate control over